Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000950120-06-000561
Filing Date
2006-09-19
Accepted
2006-09-19 17:13:35
Documents
2
Period of Report
2006-09-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.1 - CURRENT REPORT form8-ka.htm 8-K/A 61718
2 FORM OF STOCK OPTION NOTICE AND LETTER AGREEMENT exhibit10_1.htm EX-10.1 24433
  Complete submission text file 0000950120-06-000561.txt   87648
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Filer) CIK: 0000875622 (see all company filings)

EIN.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-19879 | Film No.: 061098623
SIC: 2834 Pharmaceutical Preparations